Literature DB >> 21191679

c-Jun N-terminal kinase (JNK) and p38 play different roles in age-related Purkinje cell death in murine organotypic culture.

Mariaelena Repici1, Rosine Wehrlé, Xanthi Antoniou, Tiziana Borsello, Isabelle Dusart.   

Abstract

Several studies have shown that Purkinje cells die by apoptosis in organotypic slice cultures from postnatal 3-day-old (P3) mice. This cell death is age-dependent and has been proposed as indirect evidence for the programmed Purkinje cell death occurring in in vivo cerebellum. Here, we studied whether c-jun N-terminal kinase (JNK) and p38 kinase pathways contribute to the Purkinje cell death observed in cerebellar slice cultures obtained from P3 mice. Slice culture treatment with D-JNKI1 or SB203580, respectively inhibitors of JNK and p38 MAP kinases, results in a better survival of Purkinje cells. Interestingly, the combined treatment with the two inhibitors potentiated single treatment effects. These results suggest that p38 and JNK pathways might be differently implicated in this Purkinje cell death. Time course experiments found p38 activation immediately post-slicing, whereas JNK activation was detected only 2 h after the culture. We hypothesize that p38 activation might be due to the "sliced condition," and JNK activation might be more specific to P3 age-dependent cell death. The study of JNK and p38 activation in cerebellar lysates from P0 slice culture confirmed JNK activation being specific for the P3 explants, whereas p38 is activated both from P0 and P3 cerebellar slice culture lysates. These results suggest that p38 is activated by the slicing, whereas JNK activation is related to developmental Purkinje cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21191679     DOI: 10.1007/s12311-010-0244-z

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  33 in total

1.  Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration.

Authors:  Abdel M Ghoumari; Rosine Wehrlé; Chris I De Zeeuw; Constantino Sotelo; Isabelle Dusart
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 2.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.

Authors:  Sanjay Kumar; Jeffrey Boehm; John C Lee
Journal:  Nat Rev Drug Discov       Date:  2003-09       Impact factor: 84.694

3.  Microglia promote the death of developing Purkinje cells.

Authors:  José Luis Marín-Teva; Isabelle Dusart; Catherine Colin; Annie Gervais; Nico van Rooijen; Michel Mallat
Journal:  Neuron       Date:  2004-02-19       Impact factor: 17.173

4.  Increased cerebellar Purkinje cell numbers in mice overexpressing a human bcl-2 transgene.

Authors:  H S Zanjani; M W Vogel; N Delhaye-Bouchaud; J C Martinou; J Mariani
Journal:  J Comp Neurol       Date:  1996-10-21       Impact factor: 3.215

5.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

6.  Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons.

Authors:  Won-Seok Choi; Dae-Seok Eom; Baek S Han; Won K Kim; Byung H Han; Eui-Ju Choi; Tae H Oh; George J Markelonis; Jin W Cho; Young J Oh
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

7.  Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum.

Authors:  A M Ghoumari; I Dusart; M El-Etr; F Tronche; C Sotelo; M Schumacher; E-E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

8.  c-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion.

Authors:  Fabrizio Ortolano; Alessio Colombo; Elisa Roncati Zanier; Allessandra Sclip; Luca Longhi; Carlo Perego; Nino Stocchetti; Tiziana Borsello; Maria Grazia De Simoni
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

9.  Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.

Authors:  M Repici; C Centeno; S Tomasi; G Forloni; C Bonny; A Vercelli; T Borsello
Journal:  Neuroscience       Date:  2007-08-28       Impact factor: 3.590

Review 10.  Specific activities of individual c-Jun N-terminal kinases in the brain.

Authors:  W Haeusgen; R Boehm; Y Zhao; T Herdegen; V Waetzig
Journal:  Neuroscience       Date:  2009-04-11       Impact factor: 3.590

View more
  4 in total

1.  JNK Inhibitor SP600125 Attenuates Paraquat-Induced Acute Lung Injury: an In Vivo and In Vitro Study.

Authors:  Haitao Shen; Na Wu; Yu Wang; Xinfei Han; Qiang Zheng; Xue Cai; Honglei Zhang; Min Zhao
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

2.  Enhanced survival of wild-type and Lurcher Purkinje cells in vitro following inhibition of conventional PKCs or stress-activated MAP kinase pathways.

Authors:  Hadi S Zanjani; Ann M Lohof; Rebecca McFarland; Michael W Vogel; Jean Mariani
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

3.  Profound morphological and functional changes of rodent Purkinje cells between the first and the second postnatal weeks: a metamorphosis?

Authors:  Isabelle Dusart; Frederic Flamant
Journal:  Front Neuroanat       Date:  2012-04-11       Impact factor: 3.856

4.  JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injury.

Authors:  Jiang Long; Li Cai; Jintao Li; Lei Zhang; Haiyang Yang; Tinghua Wang
Journal:  Neural Regen Res       Date:  2013-06-05       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.